Материалов:
1 005 021

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 17838

Страница 3 из 1784

Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson’s diseaseParkinson’s disease (PD) is a progressive neurodegenerative disease with limited treatment options

Parkinson’s disease: Alpha synuclein, heme oxygenase and biotherapeutic countermeasures
, physical vitality, and fundamental dignity cannot be understated. Parkinson’s disease (PD), one of the most

Electroencephalograms features of the early stage Parkinson’s disease background electrical activity is described. It is used to detect at least three main features of Parkinson’s

Assessment of copper, iron, zinc and manganese status and speciation in patients with Parkinson's disease: A pilot study), and manganese (Mn) status (hair, serum, and urine) and speciation (serum) in Parkinson's disease (PD) patients

Nutritional modulation of the intestinal microbiota: future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease microbiome and neuroimmune and neuroinflammatory diseases. In most cases, it is unknown if these associations

It diagnostics of parkinson's disease based on voice markers and decreased motor activityThe objectives of the article to propose the method for complex recognition of Parkinson's disease

Ubiquitin-Proteasome System: Promising Therapeutic Targets in Autoimmune and Neurodegenerative Diseases human diseases. Building on the prolific success of targeting the ubiquitin-proteasome system in cancer

Role of digital biomarkers in neurodegenerative diseases with Multiple Sclerosis (MS), Alzheimer‘s Disease (AD), and Parkinson‘s Disease. Digital biomarkers, defined

Editorial of the special issue: recent advances in understanding of the role of synuclein family members in health and disease would facilitate the development of efficient treatments for these diseases. Revealing an interplay

Effect of dopaminergic therapy on lacrimation in Parkinson's disease; [Влияние дофаминергической терапии на слезоотделение при болезни Паркинсона]The prevalence of dry eye syndrome (DES) in Parkinson's disease (PD) reaches 87% and leads

Страница 3 из 1784